ANGIODYNAMICS INC
ANGIODYNAMICS INC is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Surgical & Medical Instruments & Apparatus.
The next scheduled catalyst is Next quarterly earnings (projected) on January 2, 2027, a projected date rather than a confirmed one. There are 2 upcoming events on record.
Cash runway is approximately 6.6 months based on the most recent reported cash position and quarterly operating burn as of 2026-08-31.
Across 11 concluded trials, 73% reached completion rather than being terminated or withdrawn.
| Date | Event | Type | Phase |
|---|---|---|---|
| January 2, 2027 est. | Next quarterly earnings (projected) | Earnings | — |
| February 15, 2029 | Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone | Trial Milestone | Phase 4 |
Track ANGO alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open ANGO in the tracker| Date | Event | Type | Phase |
|---|---|---|---|
| October 8, 2026 | 8-K filed: Material agreement, Leadership change | Corporate | — |
| October 8, 2026 | Quarterly results filed (8-K) | Earnings | — |
| July 14, 2026 | Quarterly results filed (8-K) | Earnings | — |
| April 23, 2026 | 8-K filed: Other event | Filing | — |
| April 2, 2026 | Quarterly results filed (8-K) | Earnings | — |
| February 3, 2026 | 8-K filed: Leadership change | Corporate | — |
| January 14, 2026 | 8-K filed: Reg FD disclosure | Filing | — |
| January 6, 2026 | Quarterly results filed (8-K) | Earnings | — |
| October 2, 2025 | Quarterly results filed (8-K) | Earnings | — |
| July 15, 2025 | Quarterly results filed (8-K) | Earnings | — |
| May 28, 2025 | 8-K filed: Material agreement | Corporate | — |
| April 15, 2025 | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | Trial Milestone | Phase 3 |
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.